Press Releases and Statements

Bill proposes to make dietary supplements eligible expenses in FSA/HSA accounts, allowing consumers to use tax-preferred health savings to purchase wellness products.

Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville today released the below statement following the U.S. Food and Drug Administration (FDA) approving Opill®

Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released the following statement today in response to the U.S. Food and Drug Administration’s

CHPA thanked U.S. Senator Bob Casey (D-Pa.) and U.S. Representatives Brendan Boyle (D-Pa.), Ashley Hinson (R-Iowa), and Bob Latta (R-Ohio) this week for their steadfast commitment to a healthy America and strong self-care industry. The June 20 event was held inside the Kennedy Caucus Room on Capitol Hill and was also attended by CHPA’s corporate members, Board of Directors, stakeholders, and other supporters.

CHPA President and CEO Scott Melville today released the below statement following the National Institutes of Health’s (NIH) announcement that Stefan M. Pasiakos, Ph.D., FACSM, will serve as the new director of its Office of Dietary Supplements (ODS).

CHPA Senior Vice President of Dietary Supplements Duffy MacKay today released the following statement in response to results from a recent trial finding that people ages 60 and older who took a daily multivitamin showed an estimated 3.1 fewer years of memory loss than those who took a placebo. These results are the second time a multivitamin clinical trial within the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) reached the same conclusion.

The Consumer Healthcare Products Association (CHPA) today announced the appointment of Lisa Parks, RPh, to serve as its Senior Vice President of Regulatory & Scientific Affairs.

CHPA today released the below statement following a U.S. Food and Drug Administration (FDA) joint advisory committee meeting, which concluded that Opill®, a once-daily oral contraceptive, should be approved as the first oral contraceptive for use without a prescription:  

The Consumer Healthcare Products Association (CHPA) today released the below statement following the U.S. Food and Drug Administration’s (FDA) public release of briefing materials

Duffy MacKay, Consumer Healthcare Products Association (CHPA) Senior Vice President of Dietary Supplements, and co-author of the paper, Perspectives on the Use of Proprietary Blends in Dietary Supplements

CHPA’s SVP of Dietary Supplements, Duffy MacKay, responds to reporting on a recent research letter published in JAMA finding that 22 out of 25 melatonin products analyzed were mislabeled, containing variable amounts of the ingredient:

Most people who have flexible spending or health savings accounts think supplements should be covered as “medical expenses”